Ronak Miladi

562 citations
16 papers · 89 indexed · h-index 5
Topics
COVID-19 Clinical Research Studies (5 papers)Antibiotic Use and Resistance (4 papers)Antibiotic Resistance in Bacteria (4 papers)
Partner nations
IranSwitzerlandGermany

In The Last Decade

Ronak Miladi

15 papers receiving 88 citations

Peers

Ronak Miladi
Comparison fields: 5 of 45
  • Dermatology 37
  • Infectious Diseases 32
  • Immunology 14
  • Periodontics 14
  • Pathology and Forensic Medicine 11
Replace Ahmed El Kalioubie with:
Ahmed El Kalioubie France
V. Morillas‐Lahuerta Spain
Carmen Riggioni Spain
George N. Kounis Greece
Taghi Riahi Iran
María Nieto Spain
Dev Tilakaratne Australia
Morgan Rose Australia
Melike Sümbül Germany
Julien Campagne France
Ronak Miladi relative to Ahmed El Kalioubie France Ahmed El Kalioubie's profile →
Citations per field
00.5×
Ahmed El Kalioubie · 1×
Citations per year

Countries citing papers authored by Ronak Miladi

Since Specialization
Citations

This map shows the geographic impact of Ronak Miladi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronak Miladi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronak Miladi more than expected).

Fields of papers citing papers by Ronak Miladi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronak Miladi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronak Miladi. The network helps show where Ronak Miladi may publish in the future.

Co-authorship network of co-authors of Ronak Miladi

This figure shows the co-authorship network connecting the top 25 collaborators of Ronak Miladi. A scholar is included among the top collaborators of Ronak Miladi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronak Miladi. Ronak Miladi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 6
5 21
6 1
7 9
8 2
9 3
10 19
11 1
12 18
13 1
14 3
15 2
16 1

About Ronak Miladi

Ronak Miladi is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 16 papers that have together received 89 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Antibiotic Use and Resistance (4 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Dermatology (37 citations), Periodontics (14 citations) and Infectious Diseases (32 citations). Ronak Miladi has collaborated with scholars based in Iran, Switzerland and Germany. Frequent co-authors include Zeinab Mohseni Afshar, Maria Shirvani, Zeinab Aryanian, Soheil Ebrahimpour, Arefeh Babazadeh, Mohammad Barary, Babak Sayad, Mohamad Goldust, Alireza Janbakhsh and Feizollah Mansouri. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Journal of Cosmetic Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026